The Remote Patient Monitoring (RPM) market is projected to reach USD 56,945.8 million by 2030 from USD 27,720.5 million in 2024, at a CAGR of 12.7% from 2024 to 2030. The growth of the Remote Patient Monitoring (RPM) market is driven by the transformation of patient care through digital innovation, expansion of telehealth in remote patient monitoring, coupled with the rising prevalence of chronic disease, particularly among the growing geriatric population.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492
Remote Patient Monitoring (RPM) Market Dynamics:
Drivers:
1. Rising geriatic population and growing need to expand healthcare access
Restraints:
1. Healthcare Fraud
Opportunities:
1. high utility of RPM in comabating infectious diseases and epidemics
Challenge:
1. behavioral barriers, healthcare affordability, and the lack of awareness
Key Market Players of Remote Patient Monitoring (RPM) Industry:
Prominent players in the remote patient monitoring market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Oracle (US), Siemens Healthineers AG (Germany), Omron Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Clear Arch, Inc (US), Vivify Health, Inc. (US), Alten Calsoft Labs (France), Bio-Beat (Israel), VitalConnect (US), VivaLNK Inc. (US), Bardy Diagnsotics, Inc. (US), Biotronik SE & Co. KG (Germany), Brook Inc. (US), Blue Spark Technology (US), Welch Allyn (US), Health Beats (Singapore), Alive Cor, Inc. (US), TytoCare Ltd. (US), Teledoc Health Inc. (US), and iRhythm Technologies (US).
Koninklijke Philips N.V. (Netherlands)
Koninklijke Philips N.V. (Royal Philips) is the parent company of the Philips Group. The company works in four areas: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The company aims to grow in both natural ways and by buying other businesses to increase its market presence. Strategic partnerships in high-potential markets and collaborations have been Philips’ key growth strategy over the years. For example, in July 2024, Bon Secours Mercy Health (US) announced a 10-year partnership with Philips to implement and scale a new patient monitoring platform across its 49 hospitals and 1,200 care sites. Philips has made partnerships with many big healthcare companies and promising AI start-ups in the healthcare field, located in different places. in April 2024, Philips had collaborated with smartQare (Netherlands) to combine their monitoring systems. This will allow patients to be continuously monitored in and out of the hospital using wearable biosensors. Some of its major subsidiaries are Philips Oral Healthcare, LLC (US), Philips GmbH (Germany), Philips Ultrasound, Inc. (US), and Philips Consumer Lifestyle B.V. (Netherlands). It spans operations across North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
Medtronic (Ireland)
Medtronic is a global healthcare technology company based in Dublin, Ireland. It is an industry leader. The company helps healthcare systems, doctors, clinicians, and patients in more than 150 countries worldwide. It operates through four main business areas: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The Cardiovascular segment focuses on the management of heart rhythms, treatment of heart structures, and addressing issues with blood vessels. Neuroscience has various products for surgeries on the spine and brain, and for treating brain-related problems. The Medical Surgical part offers surgical tools, robots that help with surgery, and tools for looking inside the body. Finally, the Diabetes part provides advanced insulin pumps, systems that check blood sugar levels all the time, and smart insulin pens for managing Type 1 and Type 2 diabetes.
Medtronic works on getting product approvals and making partnerships to improve its product range. In August 2024, Medtronic collaborated with Abbott (US) to enhance Medtronic’s diabetes care area by incorporating Abbott’s advanced glucose monitoring technology. This will enhance Medtronic’s products and help patients manage diabetes better. Also, in January 2025, Medtronic reported that the FDA approved and launched the MyCareLink Smart Monitor, first app-based remote monitoring system in the world for pacemaker patients.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77155492
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/remote-patient-monitoring-market-77155492.html